MPCG
TMO icon

Matrix Private Capital Group’s Thermo Fisher Scientific TMO Stock Holding History

Matrix Private Capital Group’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-362
Closed -$209K – 196
2023
Q1 		$209K Buy
+362
New +$204K 0.14% 109

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Matrix Private Capital Group's TMO Position: Q2 2023 in Review

Matrix Private Capital Group sold out of Thermo Fisher Scientific (TMO) in Q2 2023, closing a stake of 362 shares — an estimated $209K sold.

Matrix Private Capital Group first reported a position in TMO in Q1 2023 and held it in 1 quarter. The position peaked at $209K in Q1 2023. 2,387 funds tracked by Wall St. Rank hold TMO as of Q2 2023.

  • Matrix Private Capital Group reported no remaining Thermo Fisher Scientific position as of Q2 2023 after selling out during the quarter.
  • Matrix Private Capital Group sold 362 Thermo Fisher Scientific shares in Q2 2023, an estimated $209K.
  • Matrix Private Capital Group first reported a position in Thermo Fisher Scientific in Q1 2023 and held it in 1 quarter.
  • Matrix Private Capital Group's Thermo Fisher Scientific position peaked at $209K in Q1 2023.
  • 2,387 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2023.

Based on Matrix Private Capital Group's 13F filing for Q2 2023, filed 14 Aug 2023.